It's not looking too good for the biotech.
Recursion Pharmaceuticals (NASDAQ: RXRX) has been a pioneer in using artificial intelligence (AI) to improve the drug discovery process. The company, founded in 2013, has been working on that project ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results